Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$6.7 - $24.21 $2,103 - $7,601
314 Added 0.47%
67,647 $1.63 Million
Q2 2022

Jul 29, 2022

BUY
$3.65 - $7.3 $245,765 - $491,530
67,333 New
67,333 $269,000
Q3 2020

Nov 09, 2020

SELL
$10.34 - $15.2 $814,337 - $1.2 Million
-78,756 Closed
0 $0
Q2 2020

Aug 05, 2020

BUY
$7.81 - $17.0 $615,084 - $1.34 Million
78,756 New
78,756 $1.11 Million

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0

About Provention Bio, Inc.


  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.